Keyphrases
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
100%
Hypoxic Preconditioning
66%
Acute Coronary Syndrome
52%
COVID-19
51%
Human Adipocytes
50%
Angiotensin-converting Enzyme 2 (ACE2)
50%
Interleukin-6
40%
SARS-CoV-2 Spike Protein
40%
Superoxide Dismutase
36%
Cardiovascular Risk
35%
Losartan
33%
Cigarette Smoking
33%
Preconditioning Effect
33%
Preeclampsia
33%
Atrial Septal Defect
33%
CD34+ Cells
33%
ST-elevation Myocardial Infarction (STEMI)
33%
Apolipoprotein E
29%
Percutaneous Coronary Intervention
29%
Late-onset
27%
Cardiomyocytes
26%
Indonesia
25%
Early Onset
25%
Cardiology
22%
Positive Control
22%
Fibronectin
22%
Primary Percutaneous Coronary Intervention
22%
Heat Shock Protein 27 (HSP27)
21%
Recombinant
20%
Peripheral Blood
20%
Reactive Oxygen Species
20%
Coronary Artery
19%
Interleukin-1β
19%
Endothelial Dysfunction
19%
Cigarette
19%
Spike Protein
19%
Stem Cell Proliferation
18%
Interleukin-6 Levels
18%
Cardiovascular Disease
17%
Polytetrafluoroethylene Patch
16%
Surgical Closure
16%
Cell Reprogramming
16%
Pro-survival
16%
ApoE Gene Polymorphism
16%
CD31+
16%
Human Platelet-rich Plasma
16%
Cardiomyocyte-like Cells
16%
Antigen Candidate
16%
Non-commissioned Officers
16%
Navy Personnel
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Converting Enzyme 2
50%
Interleukin 6
50%
SARS Coronavirus
49%
Cardiovascular Disease
34%
Losartan
33%
Fibronectin
33%
Heart Infarction
33%
Biological Marker
33%
Vasculotropin
30%
Cigarette Smoke
30%
Inflammation
28%
Heart Atrium Septum Defect
23%
Stem Cell Culture
23%
Tumor Necrosis Factor
22%
Cytokine
20%
Severe Acute Respiratory Syndrome
20%
Superoxide Dismutase
20%
Vascular Remodeling
20%
Endothelial Dysfunction
19%
Atherosclerosis
19%
Treatment Group
18%
Endothelial Nitric Oxide Synthase
16%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
16%
Transcription Factor GATA 4
16%
Heat Shock Protein 27
16%
Iodixanol
16%
Heart Ventricle Septum Defect
16%
Vitronectin
16%
Perindopril
16%
Vascular Cell Adhesion Molecule 1
16%
Nigella sativa
16%
Atorvastatin
16%
Politef
16%
Coronary Artery Disease
16%
Acute Coronary Syndrome
16%
Rosuvastatin
16%
Malonaldehyde
16%
Stromal Cell Derived Factor 1
16%
Platelet Derived Growth Factor BB
16%
C Reactive Protein
16%
Blood Clotting Factor
16%
Vaccine Development
16%
Acute Heart Infarction
16%
Sildenafil
16%
Combination Therapy
16%
Troponin
16%
Beraprost
16%
Pulmonary Hypertension
16%
Non Insulin Dependent Diabetes Mellitus
16%
Congestive Heart Failure
16%
Medicine and Dentistry
Cardiovascular Risk
33%
Pre-Eclampsia
30%
Atrial Septal Defect
23%
Cardiology
20%
Coronary Artery
19%
Infection
19%
Atherosclerosis
19%
Acute Coronary Syndrome
19%
COVID-19
16%
Apolipoprotein E
16%
Pericarditis
16%
Rosuvastatin
16%
Coronary Artery Disease
16%
Gensini Score
16%
Aortic Intima
16%
Platelet Derived Growth Factor BB
16%
Intima-Media Thickness
16%
Mesenchymal Stem Cell
16%
Fibronectin
16%
Cigarette Smoke
16%
Vascular Cell Adhesion Molecule 1
16%
Biological Marker
16%
Adipose-Derived Mesenchymal Stem Cell
16%
Vaccine Development
16%
Adipose Tissue
16%
Systematic Review
16%
Sildenafil
16%
Interleukin-1
16%
Ventricular Septal Defect
16%
Cytokine
16%
Endothelial Nitric Oxide Synthase
16%
Maturity Onset Diabetes of the Young
16%
Tumor Necrosis Factor
16%
Politef
16%
Combination Therapy
16%
Peripheral Blood Mononuclear Cell
16%
Pulmonary Hypertension
16%
Beraprost
16%
Cell Proliferation
16%
Blood Clot Lysis
16%
Thrombus
16%
Interleukin 6
16%
Thymus Cancer
16%
Metabolic Syndrome
10%
Treatment Group
10%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Iodixanol
8%
Coronary Angiography
7%
Pericardial Fluid
7%
Cigarette Smoking
7%